Co-founder and Chief Scientific Officer
Brendan Kennedy is the chief scientific officer of OncoRes Medical, which has developed a medical imaging probe to assist surgeons remove tumours during surgery. This reduces the number of additional surgeries required, currently by up to 25 per cent. Dr Kennedy has led each aspect of the development, from initial proof-of-principle experiments to clinical studies, pitching to venture capitalists and commercialisation. He has created a research group comprising the next generation of entrepreneurs, BRITElab, for which he secured research funding of over $5 million.